Cargando…

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08

In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007–08 se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauge, Siri H., Dudman, Susanne, Borgen, Katrine, Lackenby, Angie, Hungnes, Olav
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657637/ https://www.ncbi.nlm.nih.gov/pubmed/19193257 http://dx.doi.org/10.3201/eid1502.081031

Ejemplares similares

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
por: Meijer, Adam, et al.
Publicado: (2009)

Community spread and late season increased incidence of oseltamivir‐resistant influenza A(H1N1) viruses in Norway 2016
por: Bragstad, Karoline, et al.
Publicado: (2019)

Genomic Diversity of Oseltamivir-Resistant Influenza Virus A (H1N1), Luxembourg, 2007–08
por: Gerloff, Nancy A., et al.
Publicado: (2009)

Human to animal transmission of influenza A(H1N1)pdm09 in a turkey breeder flock in Norway
por: Sjurseth, Siri Kulberg, et al.
Publicado: (2017)

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
por: Brookes, Daniel W., et al.
Publicado: (2011)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
por: Calatayud, Laurence, et al.
Publicado: (2011)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
por: Ujike, Makoto, et al.
Publicado: (2010)

Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy
por: Esposito, Susanna, et al.
Publicado: (2010)

The epidemiology of gonorrhoea in Norway, 1993–2007: past victories, future challenges
por: Jakopanec, Irena, et al.
Publicado: (2009)

Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008
por: Dijkstra, Frederika, et al.
Publicado: (2011)

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway
por: Guzmán Herrador, Bernardo Rafael, et al.
Publicado: (2012)

Burden of medically attended influenza in Norway 2008‐2017
por: Hauge, Siri Helene, et al.
Publicado: (2019)

Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study
por: Laake, Ida, et al.
Publicado: (2018)

Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2009)

Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
por: Reddy, David
Publicado: (2010)

Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2007)

Risk conditions in children hospitalized with influenza in Norway, 2017–2019
por: Hauge, Siri Helene, et al.
Publicado: (2020)

High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
por: Bragstad, Karoline, et al.
Publicado: (2015)

Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study
por: Voltersvik, Pål, et al.
Publicado: (2016)

Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
por: de Mário Marin, Márcia Lúcia, et al.
Publicado: (2010)

Correction to: Risk conditions in children hospitalized with influenza in Norway, 2017–2019
por: Hauge, Siri Helene, et al.
Publicado: (2021)

Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy
por: Savic, Miloje, et al.
Publicado: (2017)

Detection of anti‐NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases
por: Robertson, Anna Hayman, et al.
Publicado: (2020)

Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
por: Besselaar, Terry G., et al.
Publicado: (2008)

Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
por: Kiso, Maki, et al.
Publicado: (2010)

Oseltamivir‐resistant influenza A 2009 H1N1 virus in immunocompromised patients
por: Couturier, Brianne A., et al.
Publicado: (2010)

Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
por: Li, Yinghua, et al.
Publicado: (2017)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
por: Matsuzaki, Yoko, et al.
Publicado: (2010)

PIV-33 Detection of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation during 2007–2008 influenza season from central and eastern part of Turkey
por: Carhan, A., et al.
Publicado: (2009)

Comparisons of oseltamivir‐resistant (H275Y) and concurrent oseltamivir‐susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009
por: Chan, Martin C. W., et al.
Publicado: (2012)

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness
por: Tunheim, Gro, et al.
Publicado: (2019)

Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan
por: Liu, Chia-Hung, et al.
Publicado: (2013)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
por: Laurie, Karen L., et al.
Publicado: (2015)

OP4-1 Surveillance and oseltamivir resistance of human influenza A virus in Turkey during the 2007–2008 season
por: Ciblak, M.A., et al.
Publicado: (2009)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
por: Baz, Mariana, et al.
Publicado: (2018)

Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages
por: Janies, Daniel A, et al.
Publicado: (2010)

Shedding of the Pandemic Swine-Origin Influenza A Virus (H1N1) after Oseltamivir Administration
por: Weng, Leiyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ts04feapsnpljrrk6e7ulesrs6